Indiana University Research and Technology Corporation
发明人:
Sophie PACZESNY
申请号：
US15521783
公开号：
US20170248612A1
申请日:
2015.10.26
申请国别(地区):
US
年份:
2017
代理人:
摘要：
Disclosed are biomarker panels for evaluating subjects at risk of sinusoidal obstruction syndrome (SOS) early after hematopoietic stem cell transplantation (HSCT). In particular, the present disclosure relates to the use of one or more of ST2, ANG2, L-Ficolin, HA, and VCAM1 for prognosing, diagnosing, and/or treating SOS.
